By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Next-generation sequencing technology firm GnuBio has completed its Series A equity financing round raising $8 million, which the company will use to accelerate the beta program for its platform.

The round had 12 participants, though company CEO John Boyce declined to identify them. GnuBio raised the first $3 million of the round in November and raised the remaining $5 million upon hitting certain milestones, he said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.